Literature DB >> 22364837

INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.

David R Sullivan1, Ian Hamilton-Craig, Frank van Bockxmeer, Gerald F Watts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364837     DOI: 10.1016/j.hlc.2011.11.006

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


× No keyword cloud information.
  6 in total

1.  Incomplete knowledge of the clinical context as a barrier to interpreting incidental genetic research findings.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

Review 2.  Statins for children with familial hypercholesterolemia.

Authors:  Alpo Vuorio; Jaana Kuoppala; Petri T Kovanen; Steve E Humphries; Serena Tonstad; Albert Wiegman; Euridiki Drogari; Uma Ramaswami
Journal:  Cochrane Database Syst Rev       Date:  2017-07-07

3.  Statins for children with familial hypercholesterolemia.

Authors:  Alpo Vuorio; Jaana Kuoppala; Petri T Kovanen; Steve E Humphries; Serena Tonstad; Albert Wiegman; Euridiki Drogari; Uma Ramaswami
Journal:  Cochrane Database Syst Rev       Date:  2019-11-07

4.  Assessment of physicians' awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: Is there a gap?

Authors:  Mohammed Ali Batais; Turky H Almigbal; Aref A Bin Abdulhak; Hani B Altaradi; Khalid F AlHabib
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

5.  Assessment of medical intern's knowledge, awareness and practice of familial hypercholesterolemia at academic institutes in Jeddah, Saudi Arabia.

Authors:  Sami H Alzahrani; Abdulhadi Bima; Mohammed R Algethami; Zuhier Awan
Journal:  Lipids Health Dis       Date:  2020-05-21       Impact factor: 3.876

Review 6.  Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.

Authors:  Alpo Vuorio; Petri T Kovanen
Journal:  Nutrients       Date:  2018-12-01       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.